0001650840-17-000005.txt : 20171218 0001650840-17-000005.hdr.sgml : 20171218 20171215191515 ACCESSION NUMBER: 0001650840-17-000005 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171218 DATE AS OF CHANGE: 20171215 EFFECTIVENESS DATE: 20171218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dance Biopharm Holdings, Inc. CENTRAL INDEX KEY: 0001650840 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-300966 FILM NUMBER: 171260133 BUSINESS ADDRESS: STREET 1: 2 MINT PLAZA, SUITE 804 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: 415-369-9415 MAIL ADDRESS: STREET 1: 2 MINT PLAZA, SUITE 804 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc. DATE OF NAME CHANGE: 20150812 D 1 primary_doc.xml X0708 D LIVE 0001650840 Dance Biopharm Holdings, Inc. 2 MINT PLAZA, SUITE 804 SAN FRANCISCO CA CALIFORNIA 94103 415-369-9415 DELAWARE SAV Holdings Corp. Dance BioPharm Holdings, Inc. Corporation true 2013 John S. Patton, Ph.D 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Director Donald D. Huffman 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Director Lisa E. Porter, M.D. 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Executive Officer Vivian Yan 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Director Steven Thornton 2 Mint Plaza, Suite 804 San Francisco CA CALIFORNIA 94103 Director Adam K. Stern c/o Aegis Capital Corp. 810 Seventh Ave., 18th Floor New York NY NEW YORK 10019 Director Biotechnology Decline to Disclose 06b false 2017-11-30 false true true true false 0 Aegis Capital Corp 15007 None None 810 Seventh Avenue, 18th Floor New York NY NEW YORK 10019 CA CALIFORNIA CT CONNECTICUT FL FLORIDA IL ILLINOIS IN INDIANA IA IOWA MD MARYLAND MA MASSACHUSETTS MN MINNESOTA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO TN TENNESSEE TX TEXAS VA VIRGINIA WA WASHINGTON false 40000000 14696404 25303596 false 100 3300000 true 0 Placement Agent is entitled to receive up to 10% cash and expense fees. Assumes maximum offering sold. Does not include value of warrants or royalty payment rights issuable to Placement Agent 0 true Proceeds to be used as working capital, including payment of officer and employee salaries. A portion of the proceeds to be used to compensate Placement Agent. Adam Stern, a director of the issuer, is an affiliate of the Placement Agent. false Dance Biopharm Holdings, Inc. /John S. Patton Ph.D/ John S. Patton Ph.D Chief Executive Officer 2017-12-15